Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring the Efficacy of Surgical and Percutaneous Neuroablative Procedures in the Management of Plateaued or Refractory Upper-extremity Spasticity.

NCT04670783 is registered in ClinicalTrials.gov with Vancouver Island Health Authority as lead sponsor.

NCT NCT04670783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04670783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring the Efficacy of Surgical and Percutaneous Neuroablative Procedures in the Management of Plateaued or Refractory Upper-extremity Spasticity.
Lead sponsor
Vancouver Island Health Authority
Phase
Observational
Overall status
Completed
Start date
September 15, 2020
Completion date
May 30, 2023
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnostic nerve block, multidisciplinary approach, novel algorithm, percutaneous neuroablative procedures, refractory spasticity, surgery, upper extermity spasticity